Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Conference titles: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). Unidade: FM
Subjects: NEOPLASIAS PROSTÁTICAS, PROSTATECTOMIA
ABNT
LESTINGI, Jean Felipe Prodocimo et al. Extended versus limited pelvic lymphadenectomy during radical prostatectomy for intermediate- and high-risk prostate cancer: early outcomes from a randomized controlled phase III study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://observatorio.fm.usp.br/handle/OPI/26598. Acesso em: 20 maio 2024. , 2017APA
Lestingi, J. F. P., Guglielmetti, G., Pontes Junior, J., Mitre, A. I., Sarkis, A., Bastos, D. A., et al. (2017). Extended versus limited pelvic lymphadenectomy during radical prostatectomy for intermediate- and high-risk prostate cancer: early outcomes from a randomized controlled phase III study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://observatorio.fm.usp.br/handle/OPI/26598NLM
Lestingi JFP, Guglielmetti G, Pontes Junior J, Mitre AI, Sarkis A, Bastos DA, Riechelmann R, Mattedi RL, Srougi M, Nahas WC. Extended versus limited pelvic lymphadenectomy during radical prostatectomy for intermediate- and high-risk prostate cancer: early outcomes from a randomized controlled phase III study [Internet]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 ;35[citado 2024 maio 20 ] Available from: http://observatorio.fm.usp.br/handle/OPI/26598Vancouver
Lestingi JFP, Guglielmetti G, Pontes Junior J, Mitre AI, Sarkis A, Bastos DA, Riechelmann R, Mattedi RL, Srougi M, Nahas WC. Extended versus limited pelvic lymphadenectomy during radical prostatectomy for intermediate- and high-risk prostate cancer: early outcomes from a randomized controlled phase III study [Internet]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 ;35[citado 2024 maio 20 ] Available from: http://observatorio.fm.usp.br/handle/OPI/26598